18 min listen
Dr. Ameet Sarpatwari on state bills that aim to reduce drug spending by requiring companies to disclose R&D costs.
FromNEJM Interviews
Dr. Ameet Sarpatwari on state bills that aim to reduce drug spending by requiring companies to disclose R&D costs.
FromNEJM Interviews
ratings:
Length:
10 minutes
Released:
Jun 15, 2016
Format:
Podcast episode
Description
Dr. Ameet Sarpatwari is an epidemiologist in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. A. Sarpatwari, J. Avorn, and A.S. Kesselheim. State Initiatives to Control Medication Costs — Can Transparency Legislation Help? N Engl J Med 2016;374:2301-4.
Released:
Jun 15, 2016
Format:
Podcast episode
Titles in the series (100)
NEJM Interview: Dr. Pieter Cohen on the regulation of dietary supplements. by NEJM Interviews